Browse protocols

Explore structured, USDM-based clinical trial protocols. Browsing is open to everyone.

Filter protocols

Showing 10 protocols.

A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder who Have had an Inadequate Response to Antidepressants Alone
v1.0

Sponsor Organization 3111-302-001

Phase Phase III Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 128 21
View details
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of RO5459072 in Patients With Primary Sjogren's Syndrome
v1.0

Sponsor Organization BP30037

Phase Phase II Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 132 22
View details
A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840
v2

Alexion ALXN1840-WD-204

Draft
Phase Phase II Trial
Type Interventional Study
Date added 22 Jul 2026
CDISC CORE 167 24
View details
A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840
v2

Alexion ALXN1840-WD-204

Phase Phase II Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 192 1
View details
A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients with Diabetes Mellitus
v1

Eli Lilly Japan K.K I8R-JE-IGBJ

Phase Phase III Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 190 0
View details
A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients with Diabetes Mellitus
v1

Eli Lilly Japan K.K I8R-JE-IGBJ

Draft
Phase Phase III Trial
Type Interventional Study
Date added 12 Jun 2026
CDISC CORE Not run
View details
Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate Efficacy and Safety of BAY2433334 in Patients Following an Acute Non-cardioembolic Ischemic Stroke
v1.0

Sponsor Organization 19766

Phase Phase IIb Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 132 22
View details
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimer's Disease
v2

Eli Lilly H2Q-MC-LZZT

Phase Phase II Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 200 0
View details
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimer's Disease
v2

Eli Lilly H2Q-MC-LZZT

Phase Phase II Trial
Type Interventional Study
Date added 16 Jun 2026
CDISC CORE 193 0
View details
Something Very Official
v1

ClinicalTrials.gov NCT12345678

Phase N/A
Type Observational Study
Date added 16 Jun 2026
CDISC CORE 191 0
View details